LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Home・Stock List・Sanofi

Sanofi

Closed

57.74 -0.89

Buy Sell

Overview

Share price change

24h

Current

Min

57.61

Max

57.79

Key metrics
By Trading Economics
Income	-20M 1.1B
Sales	262M 11B
P/E Sector Avg	25.1 103.001
EPS	0.455
Profit margin	9.78
EBITDA	-136M 2B

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+0.47 upside

Market Stats
By TradingEconomics
Market Cap	142B
Previous open	58.63
Previous close	57.74

Technical Score

By Trading Central

Confidence

Neutral Evidence

56.21 / 58.15 Support & Resistance

Sanofi Chart

Related News

25 Jul 2024, 05:44 UTC

Earnings

Sanofi Raises Guidance After Profit, Sales Beat

4 Jul 2024, 06:44 UTC

Acquisitions, Mergers, Takeovers

Bain, Cinven Explore Joint Bid for Sanofi's Consumer Unit, Bloomberg Reports

27 Jun 2024, 10:54 UTC

Major Market Movers

Vigil Neuroscience Shares Soar on $40 Million Sanofi Investment

26 Jun 2024, 07:15 UTC

Acquisitions, Mergers, Takeovers

Sanofi Starts Bidding Process to Sell Consumer Health Division, Bloomberg Reports

13 May 2024, 18:14 UTC

Major Market Movers

Novavax Shares Pop Another 50% Following Sanofi Deal

25 Jul 2024, 13:20 UTC

Earnings

AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook -- IBD

25 Jul 2024, 11:46 UTC

Market Talk

Earnings

Sanofi Aims to Boost RSV Drug Supply -- Market Talk

25 Jul 2024, 11:23 UTC

Market Talk

Earnings

Sanofi Results Are Positive -- Market Talk

25 Jul 2024, 05:33 UTC

Earnings

Analysts Saw Sanofi 2Q Sales at EUR10.4B

25 Jul 2024, 05:33 UTC

Earnings

Sanofi 2Q Sales EUR10.745B

25 Jul 2024, 05:30 UTC

Earnings

Sanofi Had Seen 2024 Business Earnings Per Share Decreasing Low Single Digit at Constant Currency

25 Jul 2024, 05:30 UTC

Earnings

Sanofi Now Expects 2024 Business Earnings Per Share to Be Stable at Constant Currency

25 Jul 2024, 05:30 UTC

Earnings

Analysts Saw Sanofi 2Q Business Operating Income at EUR2.69B

25 Jul 2024, 05:30 UTC

Earnings

Sanofi 2Q Net Pft EUR1.11B

25 Jul 2024, 05:30 UTC

Earnings

Sanofi Raises 2024 View

25 Jul 2024, 05:30 UTC

Earnings

Sanofi 2Q Business Operating Income EUR2.81B

9 Jul 2024, 09:05 UTC

Peer Comparison

Price change

Sanofi Forecast

Price Target

By TipRanks

0.47% upside

12 Months Forecast

Average 58 USD 0.47%

High 60 USD

Low 56 USD

Based on 3 Wall Street analysts offering 12 month price targets forSanofi - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

Buy

Hold

Sell

Based on 3 analysts giving stock ratings to Sanofi - Dist in the past 3 months.

Technical Score

By Trading Central

56.21 / 58.15Support & Resistance

The bullish and bearish events are balanced.

All events are bullish.

Recent bullish events outweigh bearish events.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

EBITDA

Operating profit

About Sanofi

Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.